Director, Global Medical Epidemiology
Pfizer, Inc.
Shilpa Viswanathan, PhD, MS, is a Director in the Global Medical Epidemiology team at Pfizer in New York, NY. Dr. Viswanathan is a pharmacoepidemiologist with over 15 years' combined experience working on observational and interventional studies in the real-world in the pharmaceutical industry, CRO and academia across therapeutic areas. In her current role at Pfizer, she is responsible for generating real-world evidence (RWE) through the product lifecycle in rare diseases, internal medicine and oncology to provide more insight into the natural history of disease, treatment safety and effectiveness using real-world data (RWD), strategic and innovative epidemiologic reseach methodologies. Her prior roles have included working with the Global Epidemiology team at IQVIA, and as a post-doctoral researcher at the Johns Hopkins University. Dr. Viswanathan received a PhD in Epidemiology with a focus on Pharmacoepidemiology from the Johns Hopkins Bloomberg School of Public Health and a Master of Science degree in Pharmacy Administration with a focus on Health Economics and Outcomes Research from the University of the Sciences in Philadelphia. She has co-authored several peer-reviewed publications and has presented her work at national and international professional meetings.